University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease : a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Simple item page
dc.contributor.authorGauthier, Serge
dc.contributor.authorFeldman, Howard H
dc.contributor.authorSchneider, Lon S
dc.contributor.authorWilcock, Gordon K
dc.contributor.authorFrisoni, Giovanni B
dc.contributor.authorHardlund, Jiri H
dc.contributor.authorMoebius, Hans J
dc.contributor.authorBentham, Peter
dc.contributor.authorKook, Karin A
dc.contributor.authorWischik, Damon J
dc.contributor.authorSchelter, Bjoern O
dc.contributor.authorDavis, Charles S
dc.contributor.authorStaff, Roger T
dc.contributor.authorBracoud, Luc
dc.contributor.authorShamsi, Kohkan
dc.contributor.authorStorey, John M D
dc.contributor.authorHarrington, Charles R
dc.contributor.authorWischik, Claude M
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Physicsen
dc.contributor.institutionUniversity of Aberdeen.Institute for Complex Systems and Mathematical Biology (ICSMB)en
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Chemistryen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2017-05-16T23:02:36Z
dc.date.available2017-05-16T23:02:36Z
dc.date.embargoedUntil2017-05-16
dc.date.issued2016-12
dc.descriptionThe study was financed by TauRx Therapeutics Ltd.en
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent1021213
dc.format.extent33110
dc.identifier69486252
dc.identifier6d02e8cb-d993-4812-bf56-ca4a88db025f
dc.identifier85003441308
dc.identifier.citationGauthier, S, Feldman, H H, Schneider, L S, Wilcock, G K, Frisoni, G B, Hardlund, J H, Moebius, H J, Bentham, P, Kook, K A, Wischik, D J, Schelter, B O, Davis, C S, Staff, R T, Bracoud, L, Shamsi, K, Storey, J M D, Harrington, C R & Wischik, C M 2016, 'Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease : a randomised, controlled, double-blind, parallel-arm, phase 3 trial ', The Lancet, vol. 388, no. 10062, pp. 2873-2884. https://doi.org/10.1016/S0140-6736(16)31275-2en
dc.identifier.doi10.1016/S0140-6736(16)31275-2
dc.identifier.iss10062en
dc.identifier.issn0140-6736
dc.identifier.otherORCID: /0000-0002-5261-5467/work/73579120
dc.identifier.otherORCID: /0000-0003-2250-3920/work/47672890
dc.identifier.urihttp://hdl.handle.net/2164/8639
dc.identifier.vol388en
dc.language.isoeng
dc.relation.ispartofThe Lanceten
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleEfficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease : a randomised, controlled, double-blind, parallel-arm, phase 3 trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Gauthier_et_al_R2_Supplementary_tables_19July2016.docx
Size:
32.33 KB
Format:
Unknown data format
Download
Thumbnail Image
Name:
Gauthier_et_al_R2_19July2016_FINAL_CLEAN.pdf
Size:
997.28 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Medicine research
Chemistry research
Medical Sciences research
Physics research
University Office research